Tested Applications
| Positive WB detected in | human saliva tissue |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:1000 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
19935-1-AP targets CST2-Specific in WB, IHC, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
Peptide Predict reactive species |
| Full Name | cystatin SA |
| Calculated Molecular Weight | 16 kDa |
| Observed Molecular Weight | 12-15 kDa |
| GenBank Accession Number | NM_001322 |
| Gene Symbol | CST2 |
| Gene ID (NCBI) | 1470 |
| RRID | AB_2878627 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | P09228 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
CST2, also named as Cystatin-2 and Cystatin-S5, belongs to the cystatin family. CST2 is a T a secreted thiol protease inhibitor found at high levels in saliva, tears and seminal plasma. This antibody is specific to CST2.
Protocols
| Product Specific Protocols | |
|---|---|
| WB protocol for CST2-Specific antibody 19935-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The CST2-Specific Polyclonal antibody (Cat# 19935-1-AP) has 3 total citations. These appear in Cell Research, Cancer Cell International, and Archives of Biochemistry and Biophysics. The associated research fields include breast cancer bone metastasis suppression, prostate cancer metastasis gene identification, and esophageal cancer proliferation, metastasis, and angiogenesis. All studies used human samples with WB and/or IHC applications.
| Species | Application | Title |
|---|---|---|
Cell Res Differential secretome analysis reveals CST6 as a suppressor of breast cancer bone metastasis. | ||
Cancer Cell Int Identification of novel key genes associated with the metastasis of prostate cancer based on bioinformatics prediction and validation.
| ||
Arch Biochem Biophys SPI1 mediates CST2 transcription to promote the proliferation, metastasis, and angiogenesis of esophageal cancer.
|
